This company has been marked as potentially delisted and may not be actively trading. NASDAQ:IMRA IMARA (IMRA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsInsider TradesTrendsBuy This Stock About IMARA Stock (NASDAQ:IMRA) Get IMARA alerts:Sign Up Key Stats Today's Range$37.21▼$38.4950-Day Range$6.32▼$25.2852-Week Range$0.97▼$6.32Volume3,667 shsAverage Volume138,364 shsMarket Capitalization$1.01 billionP/E Ratio767.52Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2-related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts. Read More Receive IMRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IMARA and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMRA Stock News HeadlinesBitwise Announces Monthly Distributions for IMST, ICOI, IMRA, and IGMEJuly 24, 2025 | businesswire.comImara overcoming infertility, am I appalled with blood on my face, is it a pregnancy symptom?May 20, 2025 | msn.comForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be the biggest paradigm shift ever. Yes, even bigger than AI. And he found one Seattle company that's at the center of this new $100 trillion revolution. Click here to get the name of this company, completely free of charge... | Brownstone Research (Ad)Imran Khan opens up on his comparisons to Ranbir Kapoor: 'I never considered...'May 11, 2024 | msn.comImara BlumeAugust 23, 2023 | health.usnews.comIMARA Inc. (IMRA) Stock Historical Prices & Data - Yahoo FinanceMarch 3, 2023 | finance.yahoo.comImara Announces Stockholder Approval of Merger With EnlivenFebruary 22, 2023 | finance.yahoo.comSHAREHOLDER ALERT: Weiss Law Reminds IMRA, TIG, FORG, and BRBW Shareholders About Its Ongoing InvestigationsJanuary 5, 2023 | benzinga.comSee More Headlines IMRA Stock Analysis - Frequently Asked Questions How were IMARA's earnings last quarter? IMARA Inc. (NASDAQ:IMRA) released its quarterly earnings data on Tuesday, November, 9th. The company reported ($2.20) EPS for the quarter, beating the consensus estimate of ($3.64) by $1.44. When did IMARA's stock split? IMARA's stock reverse split on the morning of Friday, February 24th 2023.The 1-4 reverse split was announced on Friday, February 24th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. When did IMARA IPO? IMARA (IMRA) raised $76 million in an initial public offering on Thursday, March 12th 2020. The company issued 4,500,000 shares at a price of $16.00-$18.00 per share. Morgan Stanley, Citigroup and SVB Leerink acted as the underwriters for the IPO. What other stocks do shareholders of IMARA own? Based on aggregate information from My MarketBeat watchlists, some other companies that IMARA investors own include NIO (NIO), Novavax (NVAX), NVIDIA (NVDA), Axsome Therapeutics (AXSM), Alibaba Group (BABA), AMC Entertainment (AMC) and BioXcel Therapeutics (BTAI). Company Calendar Last Earnings11/09/2021Today10/09/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:IMRA CIK1672619 Webwww.imaratx.com PhoneN/AFaxN/AEmployees41Year Founded2015Profitability EPS (Trailing Twelve Months)$0.05 Trailing P/E Ratio766.01 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.49 million Net MarginsN/A Pretax MarginN/A Return on Equity2.12% Return on Assets2.00% Debt Debt-to-Equity RatioN/A Current Ratio48.98 Quick Ratio48.98 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.51 per share Price / Cash Flow75.24 Book Value$3.44 per share Price / Book11.13Miscellaneous Outstanding Shares26,234,000Free Float16,449,000Market Cap$1.00 billion OptionableNot Optionable Beta1.09 Social Links Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:IMRA) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMARA Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMARA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.